Clinical and microbiological characterization of kpc-producing klebsiella pneumoniae infections in brazil
Beirão EM, Furtado JJD, Girardello R et al. (2011) Clinical and microbiological characterization of KPC-producing Klebsiella pneumoniae infections in Brazil. Braz J Infect Dis 15:69-73.
Cloverleaf test (modified hodge test) for detecting carbapenemase production in klebsiella pneumoniae: Be aware of false positive results
Carvalhaes CG, Picão RC, Nicoletti AG et al. (2009) Cloverleaf test (modified Hodge test) for detecting carbapenemase production in Klebsiella pneumoniae: be aware of false positive results. J Antimicrob Chemother 65:1-3.
Expansion of clonal complex 258 kpc-2-producing klebsiella pneumoniae in latin american hospitals: Report of the sentry antimicrobial surveillance program
Castanheira M, Costello AJ, Deshpande LM et al. (2012) Expansion of Clonal Complex 258 KPC-2-Producing Klebsiella pneumoniae in Latin American Hospitals: Report of the SENTRY Antimicrobial Surveillance Program. Antimicrob Agents Chemother 56:1668-1669.
Centers for Diseases Control and Prevention (CDC). 2012. Department of health and human services centers for disease control and prevention. Available at: http://www.cdc.gov/maso/FACM/pdfs/HICPAC/20080612 13_HICPAC_Minutes.pdf. Accessed 22 May 2012.
Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement
M100-S21, Wayne, PA
Clinical and Laboratory Standards Institute. 2011. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-First Informational Supplement. M100-S21, 30(1). Clinical and Laboratory Standards Institute, Wayne, PA.
Molecular mechanisms disrupting porin expression in ertapenem- resistant klebsiella and enterobacter spp. Clinical isolates from the uk
Doumith M, Ellington MJ, Livermore DM et al. (2009) Molecular mechanisms disrupting porin expression in ertapenem- resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J Antimicrob Chemother 63:659-667.
Detection and treatment options for klebsiella pneumoniae carbapenemases (kpcs): An emerging cause of multidrug-resistant infection
Hirsch EB, Tam VH (2010) Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection. J Antimicrob Chemother 65:1119-1125.
Caracterização molecular dos mecanismos de resistência aos antibióticos -lactâmicos em klebsiella spp. Isoladas de infecções de corrente sanguínea do projeto scope brasil
Monteiro J (2009) Caracterização molecular dos mecanismos de resistência aos antibióticos -lactâmicos em Klebsiella spp. isoladas de infecções de corrente sanguínea do Projeto SCOPE Brasil. Tese de Doutorado, Universidade Federal de São Paulo, São Paulo, 145 p.
First report of kpc-2-producing klebsiella pneumonia strains in brazil
Monteiro J, Santos AF, Asensi MD et al. (2009) First Report of KPC-2-Producing Klebsiella pneumonia strains in Brazil. Antimicrob Agents Chemother 53:333-334.
Cluster of bloodstream infections caused by kpc-2 carbapenemaseproducing klebsiella pneumoniae in manhattan
Nadkarni AB, Schliep T, Khan L et al. (2009) Cluster of bloodstream infections caused by KPC-2 carbapenemaseproducing Klebsiella pneumoniae in Manhattan. Am J Infect Control 37:121-126.
Clonal complex 258, the most frequently found multilocus sequence type complex in kpc-2-producing klebsiella pneumoniae isolated in brazilian hospitals
American J Infect Control
Nicoletti AG, Fehlberg LCC, Picão RC American J Infect Control (2012) Clonal complex 258, the most frequently found multilocus sequence type complex in KPC-2-producing Klebsiella pneumoniae isolated in Brazilian hospitals. Antimicrob Agents Chemother 56:4563-4564.
